395 related articles for article (PubMed ID: 22301003)
1. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.
Jia L; Shen J; Zhang D; Duan C; Liu G; Zheng D; Tian X; Liu Y; Zhang Q
Int J Biol Macromol; 2012 Apr; 50(3):523-9. PubMed ID: 22301003
[TBL] [Abstract][Full Text] [Related]
2. In vivo studies on the oridonin-loaded nanostructured lipid carriers.
Zheng D; Dai W; Zhang D; Duan C; Jia L; Liu Y; Zhang Q
Drug Deliv; 2012 Aug; 19(6):286-91. PubMed ID: 22928767
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers.
Luan J; Zhang D; Hao L; Qi L; Liu X; Guo H; Li C; Guo Y; Li T; Zhang Q; Zhai G
Colloids Surf B Biointerfaces; 2014 Feb; 114():255-60. PubMed ID: 24211416
[TBL] [Abstract][Full Text] [Related]
4. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC).
Doktorovová S; Araújo J; Garcia ML; Rakovský E; Souto EB
Colloids Surf B Biointerfaces; 2010 Feb; 75(2):538-42. PubMed ID: 19879736
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.
Dai W; Zhang D; Duan C; Jia L; Wang Y; Feng F; Zhang Q
J Microencapsul; 2010 May; 27(3):234-41. PubMed ID: 20113167
[TBL] [Abstract][Full Text] [Related]
6. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin.
Zheng D; Duan C; Zhang D; Jia L; Liu G; Liu Y; Wang F; Li C; Guo H; Zhang Q
Int J Pharm; 2012 Oct; 436(1-2):379-86. PubMed ID: 22732673
[TBL] [Abstract][Full Text] [Related]
7. Construction and in vitro/in vivo evaluation of 17-allylamino-17-demethoxygeldanamycin (17AAG)-loaded PEGylated nanostructured lipid carriers.
Wang Z; Wang J; Yang S; Hou S
Drug Dev Ind Pharm; 2016 Jan; 42(1):91-98. PubMed ID: 25853294
[TBL] [Abstract][Full Text] [Related]
8. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G
Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497
[TBL] [Abstract][Full Text] [Related]
9. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.
Zhang S; Wang J; Pan J
Drug Deliv; 2016 Nov; 23(9):3696-3703. PubMed ID: 27749105
[TBL] [Abstract][Full Text] [Related]
10. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
11. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption.
Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B
Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, in vitro and in vivo evaluation of PEGylated oridonin conjugates.
Shen J; Zhang D; Zhao Z; Jia L; Zheng D; Liu G; Hao L; Zhang Q; Tian X; Li C; Guo H
Int J Pharm; 2013 Nov; 456(1):80-6. PubMed ID: 23973480
[TBL] [Abstract][Full Text] [Related]
13. Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies.
Jia L; Zhang D; Li Z; Duan C; Wang Y; Feng F; Wang F; Liu Y; Zhang Q
Colloids Surf B Biointerfaces; 2010 Oct; 80(2):213-8. PubMed ID: 20621458
[TBL] [Abstract][Full Text] [Related]
14. PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A.
Wang L; Luo Q; Lin T; Li R; Zhu T; Zhou K; Ji Z; Song J; Jia B; Zhang C; Chen W; Zhu G
Drug Dev Ind Pharm; 2015; 41(7):1204-12. PubMed ID: 25010850
[TBL] [Abstract][Full Text] [Related]
15. Nanostructured lipid carriers as a delivery system of biochanin A.
Wang Q; Cheng H; Zhou K; Wang L; Dong S; Wang D; Chen W
Drug Deliv; 2013 Nov; 20(8):331-7. PubMed ID: 24111887
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of silybin-loaded nanostructured lipid carriers.
Jia LJ; Zhang DR; Li ZY; Feng FF; Wang YC; Dai WT; Duan CX; Zhang Q
Drug Deliv; 2010 Jan; 17(1):11-8. PubMed ID: 19941406
[TBL] [Abstract][Full Text] [Related]
17. Design and characterization of Amoitone B-loaded nanostructured lipid carriers for controlled drug release.
Luan J; Zhang D; Hao L; Li C; Qi L; Guo H; Liu X; Zhang Q
Drug Deliv; 2013 Nov; 20(8):324-30. PubMed ID: 24032657
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of galactosylated bovine serum albumin nanoparticles for liver-targeted delivery of oridonin.
Li C; Zhang D; Guo H; Hao L; Zheng D; Liu G; Shen J; Tian X; Zhang Q
Int J Pharm; 2013 May; 448(1):79-86. PubMed ID: 23518367
[TBL] [Abstract][Full Text] [Related]
19. PEGylated long circulating nanostructured lipid carriers for Amoitone B: preparation, cytotoxicity and intracellular uptake.
Luan J; Yang X; Chu L; Xi Y; Zhai G
J Colloid Interface Sci; 2014 Aug; 428():49-56. PubMed ID: 24910034
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
